MIRANDA SIRVINSKAS: Open Payments
NPI 1083336861 · BOURBONNAIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 23 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $717 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $109 |
| ABBVIE INC. | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Dexcom, Inc. | 1 | $42 |
| Exact Sciences Corporation | 2 | $40 |
| JAZZ PHARMACEUTICALS INC. | 1 | $40 |
| Corcept Therapeutics | 1 | $28 |
| Insulet Corporation | 1 | $28 |
| Amgen Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
Products named: Wegovy, Ozempic, Dexcom G6 Transmitter, Cologuard Collection Kit, XYWAV, LINZESS, FARXIGA, Korlym.
Industry payments across IL — which companies pay providers there.
